salmeterol xinafoate has been researched along with Recrudescence in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, TH; Kim, WJ; Lee, J; Lee, JH; Lee, JS; Lee, SD; Lee, SW; Lim, SY; Oh, YM; Park, TS; Rhee, CK; Yoo, KH; Yoon, HI | 1 |
| Chambers, MG; Dalal, AA; Earnshaw, SR; Jhingran, P; Mapel, DW; Stanford, R; Wilson, MR | 1 |
| Anzueto, A; Chinsky, K; Crater, G; Emmett, A; Feldman, G; Ferguson, GT; Kalberg, C; Knobil, K; O'Dell, D; Seibert, A | 1 |
| Bellandi, B; Parodi, G; Venditti, F | 1 |
| Buckley, NS; Ormiston, TM; Salpeter, EE; Salpeter, SR | 1 |
| Blitz, S; Diner, B; Mackey, D; Ross, S; Rowe, BH; Senthilselvan, A; Wong, E | 1 |
| Boner, AL; Ebbutt, A; Jenkins, MM; Lenney, W; Pedersen, S | 1 |
| Henrikson, SL; Rush, BR | 1 |
3 review(s) available for salmeterol xinafoate and Recrudescence
| Article | Year |
|---|---|
Chronic obstructive pulmonary disease: Useful medications for patients with recurrent symptoms.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Aminopyridines; Benzamides; Bronchodilator Agents; Budesonide; Cyclopropanes; Fluticasone; Formoterol Fumarate; Humans; Ipratropium; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Recurrence; Salmeterol Xinafoate; Theophylline; Tiotropium Bromide | 2016 |
Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Drug Administration Schedule; Ethanolamines; Female; Formoterol Fumarate; Hospitalization; Humans; Male; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Salmeterol Xinafoate; Treatment Outcome | 2006 |
Efficacy and safety of salmeterol in childhood asthma.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Albuterol; Analysis of Variance; Asthma; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Medical Records; Multicenter Studies as Topic; Peak Expiratory Flow Rate; Randomized Controlled Trials as Topic; Recurrence; Salmeterol Xinafoate; Time Factors | 1995 |
4 trial(s) available for salmeterol xinafoate and Recrudescence
| Article | Year |
|---|---|
Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes.
Topics: Administration, Inhalation; Aged; Albuterol; Androstadienes; Bronchodilator Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Fluticasone; Follow-Up Studies; Forced Expiratory Volume; Humans; Male; Pulmonary Disease, Chronic Obstructive; Recurrence; Salmeterol Xinafoate; Time Factors; Treatment Outcome | 2009 |
Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
Topics: Administration, Inhalation; Administration, Oral; Adolescent; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Albuterol; Androstadienes; Asthma; Bronchodilator Agents; Double-Blind Method; Drug Therapy, Combination; Emergency Service, Hospital; Female; Fluticasone; Humans; Male; Middle Aged; Patient Discharge; Prednisone; Quality of Life; Recurrence; Respiratory Function Tests; Salmeterol Xinafoate; Treatment Outcome | 2007 |
Efficacy and safety of salmeterol in childhood asthma.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Albuterol; Analysis of Variance; Asthma; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Medical Records; Multicenter Studies as Topic; Peak Expiratory Flow Rate; Randomized Controlled Trials as Topic; Recurrence; Salmeterol Xinafoate; Time Factors | 1995 |
Efficacy of salmeterol xinafoate in horses with recurrent airway obstruction.
Topics: Administration, Inhalation; Airway Obstruction; Albuterol; Animals; Bronchodilator Agents; Cross-Over Studies; Female; Horse Diseases; Horses; Lung; Male; Recurrence; Salmeterol Xinafoate; Treatment Outcome | 2001 |
4 other study(ies) available for salmeterol xinafoate and Recrudescence
| Article | Year |
|---|---|
Three-month treatment response and exacerbation in chronic obstructive pulmonary disease.
Topics: Adrenal Cortex Hormones; Adrenergic beta-2 Receptor Agonists; Bronchodilator Agents; Budesonide; Drug Therapy, Combination; Female; Fluticasone; Forced Expiratory Volume; Formoterol Fumarate; Humans; Male; Pulmonary Disease, Chronic Obstructive; Recurrence; Republic of Korea; Salmeterol Xinafoate; Smoking; Spirometry; Treatment Outcome | 2015 |
Cost-effectiveness of fluticasone propionate/salmeterol (500/50 microg) in the treatment of COPD.
Topics: Adult; Aged; Aged, 80 and over; Albuterol; Androstadienes; Anti-Asthmatic Agents; Cost-Benefit Analysis; Drug Costs; Female; Fluticasone; Humans; Male; Markov Chains; Middle Aged; Models, Economic; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive; Quality of Life; Recurrence; Risk; Salmeterol Xinafoate; Treatment Outcome | 2009 |
Fatal Tako-Tsubo cardiomyopathy recurrence after β2-agonist administration.
Topics: Adrenergic beta-2 Receptor Agonists; Aged, 80 and over; Albuterol; Fatal Outcome; Female; Humans; Recurrence; Salmeterol Xinafoate; Takotsubo Cardiomyopathy | 2012 |
Summaries for patients. What are the risks of using inhaled long-acting beta-agonist medications for the relief of asthma?
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Child; Drug Administration Schedule; Ethanolamines; Female; Formoterol Fumarate; Hospitalization; Humans; Male; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Salmeterol Xinafoate; Treatment Outcome | 2006 |